XW013TBIntroduction of Rozanolixizumab-noli Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 11

New Technology›Anatomical Regions›Introduction
ICD-10-PCS XW013TB
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

XW013TB is a billable ICD-10-PCS procedure code for Introduction of Rozanolixizumab-noli Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 11. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Code Identity

ICD-10-PCS Code
XW013TB
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Rozanolixizumab-noli Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 11
Parent Code
XW0
Short Description
Introduce Rozanolixizumab in Subcu, Perc, New Tech 11

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPart1Subcutaneous Tissue
5Approach3Percutaneous
6Device/Substance/TechnologyTRozanolixizumab-noli Monoclonal Antibody
7QualifierBNew Technology Group 11

Code History

FY 2026New code, effective October 1, 2025.
Replaces previously assigned code(s):
  • 3E013GC — Introduction of Oth Therap Subst into Subcu, Perc Approach

Similar Procedure Codes

Questions About XW013TB

Is XW013TB a billable code?

Yes. XW013TB is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Rozanolixizumab-noli Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 11 on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in XW013TB mean?

XW013TB breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 1 is the BodyPart (Subcutaneous Tissue); the 5th character 3 is the Approach (Percutaneous); the 6th character T is the Device/Substance/Technology (Rozanolixizumab-noli Monoclonal Antibody); the 7th character B is the Qualifier (New Technology Group 11).